Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(9)
•••
Comment by Duediligence33on May 03, 2017 3:14pm
241 Views
Post# 26199460

RE:RE:RE:RE:RE:RE:RE:RE:May 9th closing date

RE:RE:RE:RE:RE:RE:RE:RE:May 9th closing dateI agree fully with those 3 reasons and the summer lull with general markets at all time highs give me reservations too. I am long term bullish on APHRIA Health Canada delay in phase 2 go ahead for growing more product will hamper revenue short term. After May 9 closing we will see SP price direction. I may pay more in September or luck out in the summer with some kind of capitulation day. My bids are in with all my cash. I may be wrong or right it is my GAMBLE short term but Aphria will eventually beat everybody by 2020.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities